What are the risk factors for acute myeloid leukaemia?

A risk factor can change the chance of AML but does not predict that someone will develop it. Many people with AML have no clear identifiable risk factor, and having one does not establish a diagnosis. AML begins when abnormal changes in blood-forming cells disrupt the production of healthy blood cells.

Previous treatment for another cancer can sometimes be followed by therapy-related AML. Existing marrow disorders, including myelodysplastic syndromes, may also be associated with later AML. These links describe patterns, not a personal forecast.

Tell your clinician about previous cancer treatment, blood disorders, inherited conditions in your family, and workplace or household chemical exposure. Do not change prescribed treatment because of a risk concern. There is no routine test that can predict AML in every person; a blood count may be considered when symptoms or a known condition make it appropriate.

Arrange prompt medical assessment for unusual bruising or bleeding, repeated infections, persistent fever, marked tiredness, pale skin, or breathlessness. These symptoms can result from low blood counts and have many causes, but a blood test can help identify whether urgent investigation is needed.

Ask whether your medical history changes your monitoring needs, whether a full blood count is appropriate, and which symptoms should prompt urgent contact. If you have a marrow disorder, ask how it is being followed and what changes would require further testing.